These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 10690524)
1. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524 [TBL] [Abstract][Full Text] [Related]
2. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
3. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC). Bilim VN; Kawasaki T; Takahashi K; Tomita Y Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385 [TBL] [Abstract][Full Text] [Related]
4. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
5. Expression of beta-catenin in renal cell carcinoma. Zang T; Zhuang L; Zhang Z; Xin D; Guo Y Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196 [TBL] [Abstract][Full Text] [Related]
6. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741 [TBL] [Abstract][Full Text] [Related]
7. Loss of beta-catenin expression in metastatic gastric cancer. Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245 [TBL] [Abstract][Full Text] [Related]
8. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921 [TBL] [Abstract][Full Text] [Related]
9. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer. Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling. Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698 [TBL] [Abstract][Full Text] [Related]
12. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276 [TBL] [Abstract][Full Text] [Related]
13. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567 [TBL] [Abstract][Full Text] [Related]
14. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Tanyi J; Páy A; Rigó J; Nagy B; Papp Z Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313 [TBL] [Abstract][Full Text] [Related]
15. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495 [TBL] [Abstract][Full Text] [Related]
16. Expression of plakoglobin in renal cell carcinoma. Buchner A; Oberneder R; Riesenberg R; Keiditsch E; Hofstetter A Anticancer Res; 1998; 18(6A):4231-5. PubMed ID: 9891472 [TBL] [Abstract][Full Text] [Related]
17. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related]
18. Gene signatures of progression and metastasis in renal cell cancer. Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910 [TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 and bcl-X in bladder cancer. Kirsh EJ; Baunoch DA; Stadler WM J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]